OTLK icon

Outlook Therapeutics
OTLK

12 hedge funds and large institutions have $5.09M invested in Outlook Therapeutics in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$232K
2
+$136K
3
+$2.11K

Top Sellers

1
-$297K
2
-$20.1K
3
-$3.94K
4
UBS Group
UBS Group
Switzerland
-$1.69K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.32M
2
$670K
3
$561K
4
$257K
5
$152K
6
$37K
7
$29K
8
$18K
9
$16K
10
$12K
11
$10K
12
$7K